​
​

Voyager Therapeutics Ownership | Who Owns Voyager Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Voyager Therapeutics Ownership Summary

Voyager Therapeutics is owned by 64.91% institutional investors, 17.01% insiders, and 18.08% retail investors. Blackrock is the largest institutional shareholder, holding 9.30% of VYGR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.14% of its assets in Voyager Therapeutics shares.

VYGR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVoyager Therapeutics64.91%17.01%18.08%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.71M3.14%-
iShares Russell 2000 ETF1.21M2.21%-2.72K
Vanguard Institutional Extnd Mkt Idx Tr646.20K1.19%14.30K
T. Rowe Price Health Sciences622.40K1.14%-12.41K
Fidelity Small Cap Index469.64K0.86%-10.34K
Vanguard Explorer Inv457.06K0.84%-
BlackRock Health Sciences Opps Inv A445.88K0.82%-
iShares Russell 2000 Value ETF444.10K0.81%-
BlackRock Health Sciences Term Trust363.32K0.67%13.62K
iShares Biotechnology ETF320.40K0.59%-1.91K

Recent Insider Transactions

DateNameRoleActivityValue
Oct 02, 2024Fahey Sandell Jacquelyn Chief Legal OfficerSell$34.91K
Apr 02, 2024Swartz Robin Chief Operating OfficerSell$13.41K
Apr 02, 2024Sandrock Alfred President and CEOSell$119.45K
Feb 21, 2024Swartz Robin Chief Operating OfficerSell$29.55K
Feb 21, 2024Sandrock Alfred President and CEOSell$97.23K

Insider Transactions Trends

DateBuySell
2024 Q4-1
2024 Q3--
2024 Q2-2
2024 Q1-7
2023 Q4-1

VYGR Ownership FAQ

Who Owns Voyager Therapeutics?

Voyager Therapeutics shareholders are primarily institutional investors at 64.91%, followed by 17.01% insiders and 18.08% retail investors. The average institutional ownership in Voyager Therapeutics's industry, Biotech Stocks , is 45.35%, which Voyager Therapeutics exceeds.

Who owns the most shares of Voyager Therapeutics?

Voyager Therapeutics’s largest shareholders are Blackrock (5.31M shares, 9.30%), Armistice capital (5.2M shares, 9.10%), and Ecor1 capital (3.92M shares, 6.86%). Together, they hold 25.26% of Voyager Therapeutics’s total shares outstanding.

Does Blackrock own Voyager Therapeutics?

Yes, BlackRock owns 9.30% of Voyager Therapeutics, totaling 5.31M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 42.02M$. In the last quarter, BlackRock increased its holdings by 915.17K shares, a 20.81% change.

Who is Voyager Therapeutics’s biggest shareholder by percentage of total assets invested?

Great point partners is Voyager Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.43% of its assets in 1.6M Voyager Therapeutics shares, valued at 12.67M$.

Who is the top mutual fund holder of Voyager Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Voyager Therapeutics shares, with 3.14% of its total shares outstanding invested in 1.71M Voyager Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools